Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients

About 50% of Crohn’s Disease (CD) patients undergo an intestinal resection during their lifetime. Although the patients experience a fairly long period of well-being after the intestinal resection, they presented a postoperative recurrence (POR) in 40% of cases within 5 years. In this case series, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Frieri, Giuseppe, Valvano, Marco, Frassino, Sara, Faenza, Susanna, Cesaro, Nicola, Amicucci, Gianfranco, Manetta, Rosa, Viscido, Angelo, Latella, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179568/
https://www.ncbi.nlm.nih.gov/pubmed/37176570
http://dx.doi.org/10.3390/jcm12093130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179568/
https://www.ncbi.nlm.nih.gov/pubmed/37176570
http://dx.doi.org/10.3390/jcm12093130

Ejemplares similares